Trial Profile
Evaluations of Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Ataxia-Teleangiectasia Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ataxia telangiectasia
- Focus Therapeutic Use
- Acronyms IEDAT01
- Sponsors EryDel
- 19 May 2015 According to an EryDel media release, results of this 2 year extension study were published in Neurology Neuroimmunology & Neuroinflammation.
- 19 May 2015 Results published in an EryDel media release.
- 05 Feb 2013 Additional identifiers (EudraCT2010-022315-19; IEDAT-ERY01-2010) added.